Document is current
Any future updates will be listed below
-
Authors
Wang, Liqiang
Cai, Xin
Kong, Yang
Wu, Qingchun
Hu, Wei
Wang, Yongsheng
-
Funding
Funding for this research was provided by:
Sichuan Provincial Science and Technology Support Program (2024YFFK0012)
- License Information
-
More Information
Article History
Received: 30 March 2025
Accepted: 5 May 2025
First Online: 14 May 2025
Declarations
:
: The animal study protocol (protocol code B16-4–20210901-0091–20240901, approved on 01-Sep-2021) was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai ChemPartner Co., Ltd. All procedures involving animals were conducted in strict accordance with relevant national regulations and institutional guidelines for the care and use of laboratory animals.
: Not applicable to this article.
: Not applicable to this article.
: Liqiang Wang, Xin Cai, Yongsheng Wang, and Wei Hu hold equity at Chengdu Fendi Pharmaceutical Co., Ltd. Yang Kong, Qingchun Wu, and Wei Hu are employees of Chengdu Fendi Pharmaceutical Co., Ltd. The authors declare no additional conflicts of interest.
